Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study.
Identifieur interne : 000983 ( Main/Exploration ); précédent : 000982; suivant : 000984Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study.
Auteurs : Jian-Min Yuan [États-Unis] ; Lesley M. Butler ; Yu-Tang Gao ; Sharon E. Murphy ; Steven G. Carmella ; Renwei Wang ; Heather H. Nelson ; Stephen S. HechtSource :
- Carcinogenesis [ 1460-2180 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Chine, Composés organiques volatils (urine), Facteurs de risque, Femelle, Humains, Hydrocarbures aromatiques polycycliques (urine), Marqueurs biologiques tumoraux (urine), Mâle, Pronostic, Tabagisme (effets indésirables), Tumeurs du poumon (diagnostic), Tumeurs du poumon (urine), Études cas-témoins, Études de cohortes, Études de suivi.
- MESH :
- diagnostic : Tumeurs du poumon.
- effets indésirables : Tabagisme.
- urine : Adulte d'âge moyen, Chine, Composés organiques volatils, Facteurs de risque, Femelle, Humains, Hydrocarbures aromatiques polycycliques, Marqueurs biologiques tumoraux, Mâle, Pronostic, Tumeurs du poumon, Études cas-témoins, Études de cohortes, Études de suivi.
English descriptors
- KwdEn :
- Biomarkers, Tumor (urine), Case-Control Studies, China, Cohort Studies, Female, Follow-Up Studies, Humans, Lung Neoplasms (diagnosis), Lung Neoplasms (urine), Male, Middle Aged, Polycyclic Aromatic Hydrocarbons (urine), Prognosis, Risk Factors, Smoking (adverse effects), Volatile Organic Compounds (urine).
- MESH :
- chemical , urine : Biomarkers, Tumor, Polycyclic Aromatic Hydrocarbons, Volatile Organic Compounds.
- adverse effects : Smoking.
- diagnosis : Lung Neoplasms.
- urine : Lung Neoplasms.
- Case-Control Studies, China, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Risk Factors.
Abstract
Exposures to polycyclic aromatic hydrocarbons (PAHs) from various environmental and occupational sources are considered a primary risk factor for lung cancer among lifelong never smokers, based largely on results from epidemiologic studies utilizing self-reported exposure information. Prospective, biomarker-based human studies on the role of PAH and other airborne carcinogens in the development of lung cancer among lifelong non-smokers have been lacking. We prospectively investigated levels of urinary metabolites of a PAH and volatile organic compounds in relation to lung cancer risk in a nested case-control study of 82 cases and 83 controls among lifelong never smokers of the Shanghai Cohort Study, a prospective cohort of 18 244 Chinese men aged 45-64 years at enrollment. We quantified three PAH metabolites: r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT), 3-hydroxyphenanthrene (3-OH-Phe) and total hydroxyphenanthrenes (total OH-Phe, the sum of 1-, 2-, 3- and 4-OH-Phe), as well as metabolites of the volatile organic compounds acrolein (3-hydroxypropyl mercapturic acid), benzene (S-phenyl mercapturic acid), crotonaldehyde (3-hydroxy-1-methylpropylmercapturic acid) and ethylene oxide (2-hydroxyethyl mercapturic acid). Urinary cotinine was also quantified to confirm non-smoking status. Compared with the lowest quartile, odds ratios (95% confidence intervals) for lung cancer risk for the highest quartile levels of PheT, 3-OH-Phe and total OH-Phe were 2.98 (1.13-7.87), 3.10 (1.12-7.75) and 2.59 (1.01-6.65) (all P trend < 0.05), respectively. None of the metabolites of the volatile organic compounds were associated with overall lung cancer risk. This study demonstrates a potentially important role of exposure to PAH in the development of lung cancer among lifelong never smokers.
DOI: 10.1093/carcin/bgt352
PubMed: 24148823
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003D65
- to stream PubMed, to step Curation: 003D38
- to stream PubMed, to step Checkpoint: 003D38
- to stream Ncbi, to step Merge: 000449
- to stream Ncbi, to step Curation: 000449
- to stream Ncbi, to step Checkpoint: 000449
- to stream Main, to step Merge: 000989
- to stream Main, to step Curation: 000983
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study.</title>
<author><name sortKey="Yuan, Jian Min" sort="Yuan, Jian Min" uniqKey="Yuan J" first="Jian-Min" last="Yuan">Jian-Min Yuan</name>
<affiliation wicri:level="2"><nlm:affiliation>Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Butler, Lesley M" sort="Butler, Lesley M" uniqKey="Butler L" first="Lesley M" last="Butler">Lesley M. Butler</name>
</author>
<author><name sortKey="Gao, Yu Tang" sort="Gao, Yu Tang" uniqKey="Gao Y" first="Yu-Tang" last="Gao">Yu-Tang Gao</name>
</author>
<author><name sortKey="Murphy, Sharon E" sort="Murphy, Sharon E" uniqKey="Murphy S" first="Sharon E" last="Murphy">Sharon E. Murphy</name>
</author>
<author><name sortKey="Carmella, Steven G" sort="Carmella, Steven G" uniqKey="Carmella S" first="Steven G" last="Carmella">Steven G. Carmella</name>
</author>
<author><name sortKey="Wang, Renwei" sort="Wang, Renwei" uniqKey="Wang R" first="Renwei" last="Wang">Renwei Wang</name>
</author>
<author><name sortKey="Nelson, Heather H" sort="Nelson, Heather H" uniqKey="Nelson H" first="Heather H" last="Nelson">Heather H. Nelson</name>
</author>
<author><name sortKey="Hecht, Stephen S" sort="Hecht, Stephen S" uniqKey="Hecht S" first="Stephen S" last="Hecht">Stephen S. Hecht</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24148823</idno>
<idno type="pmid">24148823</idno>
<idno type="doi">10.1093/carcin/bgt352</idno>
<idno type="wicri:Area/PubMed/Corpus">003D65</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003D65</idno>
<idno type="wicri:Area/PubMed/Curation">003D38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003D38</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003D38</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003D38</idno>
<idno type="wicri:Area/Ncbi/Merge">000449</idno>
<idno type="wicri:Area/Ncbi/Curation">000449</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000449</idno>
<idno type="wicri:Area/Main/Merge">000989</idno>
<idno type="wicri:Area/Main/Curation">000983</idno>
<idno type="wicri:Area/Main/Exploration">000983</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study.</title>
<author><name sortKey="Yuan, Jian Min" sort="Yuan, Jian Min" uniqKey="Yuan J" first="Jian-Min" last="Yuan">Jian-Min Yuan</name>
<affiliation wicri:level="2"><nlm:affiliation>Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Butler, Lesley M" sort="Butler, Lesley M" uniqKey="Butler L" first="Lesley M" last="Butler">Lesley M. Butler</name>
</author>
<author><name sortKey="Gao, Yu Tang" sort="Gao, Yu Tang" uniqKey="Gao Y" first="Yu-Tang" last="Gao">Yu-Tang Gao</name>
</author>
<author><name sortKey="Murphy, Sharon E" sort="Murphy, Sharon E" uniqKey="Murphy S" first="Sharon E" last="Murphy">Sharon E. Murphy</name>
</author>
<author><name sortKey="Carmella, Steven G" sort="Carmella, Steven G" uniqKey="Carmella S" first="Steven G" last="Carmella">Steven G. Carmella</name>
</author>
<author><name sortKey="Wang, Renwei" sort="Wang, Renwei" uniqKey="Wang R" first="Renwei" last="Wang">Renwei Wang</name>
</author>
<author><name sortKey="Nelson, Heather H" sort="Nelson, Heather H" uniqKey="Nelson H" first="Heather H" last="Nelson">Heather H. Nelson</name>
</author>
<author><name sortKey="Hecht, Stephen S" sort="Hecht, Stephen S" uniqKey="Hecht S" first="Stephen S" last="Hecht">Stephen S. Hecht</name>
</author>
</analytic>
<series><title level="j">Carcinogenesis</title>
<idno type="eISSN">1460-2180</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomarkers, Tumor (urine)</term>
<term>Case-Control Studies</term>
<term>China</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lung Neoplasms (diagnosis)</term>
<term>Lung Neoplasms (urine)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polycyclic Aromatic Hydrocarbons (urine)</term>
<term>Prognosis</term>
<term>Risk Factors</term>
<term>Smoking (adverse effects)</term>
<term>Volatile Organic Compounds (urine)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Chine</term>
<term>Composés organiques volatils (urine)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hydrocarbures aromatiques polycycliques (urine)</term>
<term>Marqueurs biologiques tumoraux (urine)</term>
<term>Mâle</term>
<term>Pronostic</term>
<term>Tabagisme (effets indésirables)</term>
<term>Tumeurs du poumon (diagnostic)</term>
<term>Tumeurs du poumon (urine)</term>
<term>Études cas-témoins</term>
<term>Études de cohortes</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="urine" xml:lang="en"><term>Biomarkers, Tumor</term>
<term>Polycyclic Aromatic Hydrocarbons</term>
<term>Volatile Organic Compounds</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Smoking</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Tabagisme</term>
</keywords>
<keywords scheme="MESH" qualifier="urine" xml:lang="en"><term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term>
<term>China</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prognosis</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="urine" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Chine</term>
<term>Composés organiques volatils</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hydrocarbures aromatiques polycycliques</term>
<term>Marqueurs biologiques tumoraux</term>
<term>Mâle</term>
<term>Pronostic</term>
<term>Tumeurs du poumon</term>
<term>Études cas-témoins</term>
<term>Études de cohortes</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Exposures to polycyclic aromatic hydrocarbons (PAHs) from various environmental and occupational sources are considered a primary risk factor for lung cancer among lifelong never smokers, based largely on results from epidemiologic studies utilizing self-reported exposure information. Prospective, biomarker-based human studies on the role of PAH and other airborne carcinogens in the development of lung cancer among lifelong non-smokers have been lacking. We prospectively investigated levels of urinary metabolites of a PAH and volatile organic compounds in relation to lung cancer risk in a nested case-control study of 82 cases and 83 controls among lifelong never smokers of the Shanghai Cohort Study, a prospective cohort of 18 244 Chinese men aged 45-64 years at enrollment. We quantified three PAH metabolites: r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT), 3-hydroxyphenanthrene (3-OH-Phe) and total hydroxyphenanthrenes (total OH-Phe, the sum of 1-, 2-, 3- and 4-OH-Phe), as well as metabolites of the volatile organic compounds acrolein (3-hydroxypropyl mercapturic acid), benzene (S-phenyl mercapturic acid), crotonaldehyde (3-hydroxy-1-methylpropylmercapturic acid) and ethylene oxide (2-hydroxyethyl mercapturic acid). Urinary cotinine was also quantified to confirm non-smoking status. Compared with the lowest quartile, odds ratios (95% confidence intervals) for lung cancer risk for the highest quartile levels of PheT, 3-OH-Phe and total OH-Phe were 2.98 (1.13-7.87), 3.10 (1.12-7.75) and 2.59 (1.01-6.65) (all P trend < 0.05), respectively. None of the metabolites of the volatile organic compounds were associated with overall lung cancer risk. This study demonstrates a potentially important role of exposure to PAH in the development of lung cancer among lifelong never smokers.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
</region>
</list>
<tree><noCountry><name sortKey="Butler, Lesley M" sort="Butler, Lesley M" uniqKey="Butler L" first="Lesley M" last="Butler">Lesley M. Butler</name>
<name sortKey="Carmella, Steven G" sort="Carmella, Steven G" uniqKey="Carmella S" first="Steven G" last="Carmella">Steven G. Carmella</name>
<name sortKey="Gao, Yu Tang" sort="Gao, Yu Tang" uniqKey="Gao Y" first="Yu-Tang" last="Gao">Yu-Tang Gao</name>
<name sortKey="Hecht, Stephen S" sort="Hecht, Stephen S" uniqKey="Hecht S" first="Stephen S" last="Hecht">Stephen S. Hecht</name>
<name sortKey="Murphy, Sharon E" sort="Murphy, Sharon E" uniqKey="Murphy S" first="Sharon E" last="Murphy">Sharon E. Murphy</name>
<name sortKey="Nelson, Heather H" sort="Nelson, Heather H" uniqKey="Nelson H" first="Heather H" last="Nelson">Heather H. Nelson</name>
<name sortKey="Wang, Renwei" sort="Wang, Renwei" uniqKey="Wang R" first="Renwei" last="Wang">Renwei Wang</name>
</noCountry>
<country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Yuan, Jian Min" sort="Yuan, Jian Min" uniqKey="Yuan J" first="Jian-Min" last="Yuan">Jian-Min Yuan</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000983 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000983 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Amérique |area= PittsburghV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:24148823 |texte= Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24148823" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PittsburghV1
This area was generated with Dilib version V0.6.38. |